DAIC

JUNE 19, 2024

They include medications that are not very effective and cause unpleasant side effects, an implantable cardioverter-defibrillator (or ICD) that provides an internal shock to correct the heartbeat, and a procedure called catheter ablation. Unfortunately, ablation also destroys healthy heart tissue in the process.

Tachycardia 128

Tachycardia Cardiac Arrest Ablation Research 128

HeartRhythm

MARCH 31, 2025

Catheter VT ablation has been shown to reduce implantable cardioverter-defibrillator (ICD) shocks, however inpatient outcomes compared to medical VT management have not been established. VT is often well tolerated hemodynamically in the presence a LVAD; therefore, antiarrhythmic drugs are first-line for therapy.

Tachycardia 40

Tachycardia Ablation Inpatient Defibrillator 40

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillator (ICD) therapy improves outcomes, but recurrent VT, ICD discharges, and cardiac hospitalizations remain a source of significant morbidity and are associated with increased mortality. Anti-arrhythmic medications are effective, but long-term use is associated with significant side effects.

Tachycardia 40

Tachycardia Hospital Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Patients suffering recurrent Ventricular Tachycardia (VT) despite antiarrhythmic drugs, defibrillator and ablation remain at significant risk of morbidity and mortality. Although cardiac radioablation (RA) has demonstrated promise, results are heterogenous.

Tachycardia 40

Tachycardia Ablation Defibrillator 40

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillator (ICD) therapy improves outcomes, though recurrent VT, ICD discharges, and cardiac hospitalizations remain a source of significant morbidity and are associated with increased mortality. Anti-arrhythmic medications are generally effective, but long-term use is associated with significant side effects.

Tachycardia 40

Tachycardia Arrhythmia Ablation Defibrillator 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) ablation can improve of ventricular dysfunction

Atrial Fibrillation 40

Atrial Fibrillation Ablation Defibrillator 40

HeartRhythm

MARCH 31, 2025

Catheter ablation (CA) lowers VT recurrence and implantable cardioverter defibrillator (ICD) interventions, however, its effect on all-cause mortality remains unclear. Ventricular tachycardia (VT) increases morbidity and mortality in patients with cardiomyopathy.

Tachycardia 40

Tachycardia Defibrillator Cardiomyopathy Ablation 40

HeartRhythm

MARCH 31, 2025

Cardiac stereotactic body radiation therapy (SBRT) is a promising non-invasive approach for the treatment of ventricular tachycardia refractory to conventional therapy with ablation and antiarrhythmic drugs. Its effect on implantable cardioverter defibrillator (ICD) parameters remains unknown.

Defibrillator 40

Defibrillator Tachycardia Ablation 40

HeartRhythm

APRIL 30, 2024

Patients suffering recurrent Ventricular Tachycardia (VT) despite antiarrhythmic drugs (AAD), defibrillator (ICD) and catheter ablation (CA) remain at significant risk of morbidity and mortality.

Tachycardia 40

Tachycardia Defibrillator Ablation 40

All About Cardiovascular System and Disorders

APRIL 17, 2024

Chronic recurrent monomorphic VT like fascicular tachycardia and right ventricular outflow tract tachycardia are also amenable to electrophysiological mapping and ablation. Recurrent ventricular tachycardia in spite of radiofrequency catheter ablation needs an implantable cardioverter defibrillator.

Tachycardia 52

Tachycardia Defibrillator Congenital Ischemia 52

HeartRhythm

APRIL 30, 2024

Optimization of implantable cardioverter defibrillator (ICD) programming is essential to minimize inappropriate shocks, and to ensure appropriate ICD therapies are delivered for slower ventricular tachycardia (VT).

Tachycardia 40

Tachycardia Defibrillator Ablation 40

DAIC

JANUARY 29, 2025

AFHCUs included clinical actions such as ablation, cardioversion, initiation/intensification of rate or rhythm control medication, or progression to a pacemaker or implantable cardioverter-defibrillator. i Centers for Disease Control and Prevention. 2024, May 15). About Atrial Fibrillation.

AFIB 52

AFIB Atrial Fibrillation Quality of Life Heart Rhythm 52

DAIC

MARCH 26, 2024

Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard of care to regulate a patient’s irregular heartbeat. The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 million people in the United States by 2030, based on an estimation from the Centers for Disease Control and Prevention.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

NOVEMBER 26, 2024

AF, atrial fibrillation; ICD, implantable cardioverter defibrillator; ILR, implantable loop recorder. vs. 1.3%; p =0.996) or catheter ablation (3.8% ABSTRACT Introduction Little is known about age and clinical intervention after implantable loop recorder (ILR) insertion. The mean age was 64.3 vs. 18.6%; p <0.001).

Atrial Fibrillation 40

Atrial Fibrillation Defibrillator Pacemaker Ablation 40

HeartRhythm

SEPTEMBER 4, 2023

Over the past years, patients with tetralogy of Fallot (TOF) have experienced numerous improvements in different treatment modalities consisting of a mixture of surgical procedures, transcatheter interventions including ablation therapy, and implantable cardioverter-defibrillator implantation procedures.

Defibrillator 40

Defibrillator Tachycardia Pulmonary Ablation 40

HeartRhythm

JANUARY 8, 2025

Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered ventricular arrhythmias can persist. In this setting, epicardial substrate ablation has emerged as a promising alternative for symptomatic patients.

Sudden Cardiac Death 73

Sudden Cardiac Death Ablation Defibrillator Arrhythmia 73

HeartRhythm

MARCH 31, 2025

Implantable cardioverter-defibrillators (ICDs) are placed to prevent sudden cardiac death, but ICD shocks are known to have a negative effect on quality of life and survival. Currently, catheter ablation is used when antiarrhythmic drugs fail to suppress Ventricular Tachycardia, but its efficacy as a first-line treatment is uncertain.

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator Tachycardia Quality of Life 40

HeartRhythm

MAY 7, 2024

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

Sudden Cardiac Death 45

Sudden Cardiac Death Tachycardia Cardiomyopathy Ablation 45

HeartRhythm

JUNE 3, 2024

Recent advancements in catheter ablation for structural ventricular tachycardia (VT), such as high-density mapping and cardiac imaging-based detection of target areas, have significantly improved the efficacy of ablation procedures.

Sudden Cardiac Death 40

Sudden Cardiac Death Tachycardia Ablation Defibrillator 40

HeartRhythm

NOVEMBER 16, 2024

Historically, risk stratification electrophysiologic studies involved programmed ventricular stimulation with VT induction guiding implantable cardioverter-defibrillator (ICD) implantation or VT ablation.

Sudden Cardiac Death 40

Sudden Cardiac Death Tachycardia Ablation Tricuspid 40

HeartRhythm

APRIL 30, 2024

In the PARTITA trial antitachycardia pacing (ATP) predicted the occurrence of implantable cardioverter-defibrillator (ICD) shocks. Catheter ablation of ventricular tachycardia after the first shock reduced the risk of death or worsening heart failure (wHF).

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Tachycardia 40

HeartRhythm

MARCH 31, 2025

Ventricular tachycardia (VT) ablation in LMNA patients has high failure and recurrence rates. Cardiac sympathectomy denervation (CSD) has shown to decrease the VA and implantable cardiac defibrillator (ICD) shock burden in patients with refractory VAs.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Arrhythmia Defibrillator 40

European Journal of Heart Failure

NOVEMBER 11, 2024

Ablation will be performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx).

Heart Transplant 40

Heart Transplant Transplant Heart Failure Ablation 40

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. That is how the strategy of rhythm control by catheter ablation was thought of as a possible better strategy, though technically more challenging, not uniformly effective and having significant risk of complications. N Engl J Med.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

HeartRhythm

OCTOBER 15, 2023

Treatment options, which consist primarily of antiarrhythmic medications, catheter ablation procedures, and autonomic modulation, are limited by mediocre effectiveness, invasiveness, and side effects including potential end-organ toxicities2-4.

Sudden Cardiac Death 40

Sudden Cardiac Death Tachycardia Defibrillator Arrhythmia 40

Dr. Smith's ECG Blog

JULY 21, 2024

He required multiple defibrillations within a period of a few hours. This time, the arrhythmia did not spontaneously terminate — but rather degenerated to VFib, requiring defibrillation. Some episodes of PMVT would terminate spontaneously — but on many occasions, the PMVT degenerated to VFib, requiring defibrillation.

Arrhythmia 130

Arrhythmia Cardiogenic Shock Bradycardia Defibrillator 130

Heart BMJ

JANUARY 10, 2024

Radiofrequency ablation has shown some potential in disrupting ventricular tachycardia circuits, with combined endo and epicardial ablation yielding better results which could be considered at the index procedure. Additionally, the impact of sotalol and amiodarone is inconsistent with studies reporting contradictory results.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Defibrillator Arrhythmia 40

Circulation

NOVEMBER 11, 2024

All study participants never received alcohol septal ablation or surgical myectomy during follow-up. In the subgroup with Class 3 of recommendation for implantable cardioverter defibrillator, patients with absolute LV-GLS ≤ 9% showed significantly worse prognosis than those with absolute LV-GLS &gt; 9% (p =.002 vs -266.2;

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Defibrillator Risk Factors 40

Dr. Smith's ECG Blog

FEBRUARY 6, 2025

The patient has been scheduled for a PVC ablation procedure. Our patient was referred for EP study with a plan of PVC ablation if possible. The various idiopathic VTs usually can be controlled well with medical treatment and/or catheter ablation therapy. Once the arrhythmia was under control cardiac MRi was performed.

Tachycardia 71

Tachycardia Arrhythmia Atrial Flutter Cardiomyopathy 71